Exploring Regulatory and Reimbursement Pathways for DTx: Europe

Overview

In this session, we provide a comprehensive overview of the regulatory and reimbursement frameworks for digital therapeutics, specifically focusing on Europe. We review the frameworks in countries including France, Germany, and the United Kingdom.

Hear from our experts who have navigated these pathways, gaining valuable insights from their experiences and strategies, and answering questions including:

  • What are the regulatory pathways?
  • What are the reimbursement pathways?
  • How is the reimbursement pathway impacted by the regulatory pathway?
  • How successful are companies in each pathway to date?
  • What does a company need to do to be successful in each pathway?
  • How do we see the pathways evolving in the next 5 years?

Speakers

  • Alberta Spreafico, Senior Vice President, Health Innovation at EVERSANA
  • Jonas Albert, Partner at _fBeta
  • Hélène Viatgé, Co-CEO and Co-Founder at AppThera

Moderator

  • Emilie Lopes-Fernandes, Program Manager at American Telemedicine Association